ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

JIA: The Transition to Adult Care

Ruth Jessen Hickman, MD  |  November 5, 2025

“Use cortisone injections sparingly and with caution,” Dr. Gakhal said, “because they can affect the mandibular growth in an immature skeleton.”


Ruth Jessen Hickman, MD, photoRuth Jessen Hickman, MD, a graduate of the Indiana University School of Medicine, is a medical and science writer in Bloomington, Ind.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Sandborg CI, Schulert GS, Kimura Y. Juvenile idiopathic arthritis. N Engl J Med. 2025 Jul 10;393(2):162–174. 
  2. Angeles-Han ST, Ringold S, Beukelman T, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken). 2019 Jun;71(6):703–716. 
  3. Berard R, Ng HY, Human A, et al. Canadian Rheumatology Association recommendations for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. J Rheumatol. 2023 Mar;50(3):390–399. 
  4. Foeldvari I, Bohn M, Petrushkin H, et al. A practical approach to uveitis screening in children with juvenile idiopathic arthritis. Br J Ophthalmol. 2025 Feb 24;109(3):372–376. 
  5. Rypdal V, Glerup M, Songstad NT, et al. Uveitis in juvenile idiopathic arthritis: 18-year outcome in the population-based Nordic cohort study. Ophthalmology. 2021 Apr;128(4):598–608.
  6. Marino A, Cicinelli MV, Miserocchi E, et al. Recurrence risk in pediatric noninfectious uveitis during adalimumab tapering: An international multicenter retrospective study. Arthritis Rheumatol. 2025 Sep;77(9):1254–1262. 
  7. Acharya NR, Ramanan AV, Coyne Abet al. Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): A multicentre, double-masked, randomised controlled trial. Lancet. 2025 Jan 25;405(10475):303–313. 
  8. de Sonnaville WFC, Speksnijder CM, et al. Clinically established temporomandibular involvement in adults with juvenile idiopathic arthritis. J Rheumatol. 2023 Nov;50(11):1462–1470.
  9. Onel KB, Horton DB, Lovell DJ, et al. 2021 American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: Therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2022 Apr;74(4):553–569. 

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2025JIAJIA-associated uveitisjuvenile idiopathic arthritis (JIA)pediatric arthritistemporomandibular joint (TMJ)

Related Articles

    JIA & the Temporomandibular Joint: Diagnostic Challenges & Treatment Options

    April 10, 2020

    Juvenile idiopathic arthritis (JIA) can affect all joints, including the temporomandibular joints (TMJs). For a long time, the TMJ was a “forgotten” joint in pediatric rheumatology, although Sir Frederick Still did comment on a small mandible in his first case series on juvenile arthritis in 1897. In recent years, more attention has been given to…

    An Overview of Pediatric, Noninfectious Uveitis

    October 18, 2018

    Uveitis is an inflammation of the uvea, which comprises the iris, ciliary body and choroid. Uveitis can lead to ocular damage and complete visual loss. Noninfectious etiologies for uveitis are the most common in the U.S.1 The estimated incidence of uveitis ranges from 25–52 per 100,000 in adults and five per 100,000 in children. The…

    Watch Those Eyes

    December 1, 2007

    What you need to know about Uveitis in Rheumatic Diseases

    What Adult Rheumatologists Need to Know about Juvenile Arthritis

    May 1, 2013

    How to recognize distinctions between pediatric and adult arthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences